Scientist III, Analytical Development and Clinical Quality Control
Alexion

Join our Late Stage Analytical team at Alexion, AstraZeneca, Rare Disease, where you will play a pivotal role in managing development projects through the CMC lifecycle. This position requires analytical experience and the ability to handle multiple projects simultaneously. You will work closely with other PDCS teams, Regulatory, QA and QC laboratories to design the strategy of late-stage analytical activities. This role also involves leading the analytical team from pre-clinical through product launch and authoring for regulatory filing in relevant analytical sections.

Accountabilities:

As a Scientist III, you will interact with cross-functional teams, lead method transfer/validation activities, drive communications with collaborators, lead troubleshooting and OOS/OOT investigations, review analytical testing procedures, provide subject matter expertise for regulatory interactions, and lead all analytical late-stage activities as analytical functional lead for clinical CMC programs.

Essential Skills/Experience:

- MS degree in Biochemistry or related field with 10+ years of Industry experience or Ph.D. degree in Biochemistry or related field with 6+ years of Industry experience

- Experience in CMC structure and previous experience as project lead for analytical function

- Experience in analysis of various Biologic modalities (e.g., mAb, antibody-drug conjugate, fusion protein)

- Extensive experience in separations science (e.g., SEC, RP, IEX). Experience in Molecular biology (PCR, DNA extraction) and immunoassay (ELISA) techniques

- Experience in microbiology assays (e.g., required day of harvest, bioburden, endotoxin, sterility and CCIT)

- Background in Analytical Methodologies and sound scientific understanding of Critical Quality Attributes/QbD/DOE principles as well as data analysis and statistics

- Understanding of analytical control strategy and required analytical late-stage activities such as reference standard program, stability program and comparability

- Ability to work independently to develop and design experiments, critically evaluate data, and then iterate as part of the scientific method

- Ability to lead investigations and troubleshoot various analytical issues independently with quality and compliance in mind

- Experience of testing strategy for late-stage program in preparation for BLA filing

- Excellent written skill for drafting all the GMP related documents

- Experience authoring regulatory filings and responses.

- Excellent collaboration skills and experience working in cross-functional teams and ability to deliver complex objectives under bold timelines in a rapidly changing environment

- Extensive experience in compendia methods and multi-country compendia requirements (USP, EP, JP required, CHP preferred)

- Strong direct experience in the development, validation, and transfer of analytical methods for biological products, especially in cGMP environment as listed in ICH Q2

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

At AstraZeneca's Alexion business area, we are more than just a beacon in the global Biopharmaceutical landscape. Our closeness to patients brings us closer to our work and closer to each other. We are driven by our passion to continuously innovate and create meaningful value. We believe it is our responsibility to listen to, understand and change the lives of patients and those who work tirelessly to help them. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. We are truly unique in R&D and healthcare, and we are looking for individuals who are ready to make a difference where it truly counts.

Are you ready to join a team that values diversity, different thinking, and inclusion? Are you ready to make an impact and drive change with integrity? If this sounds like a team that you want to be a part of... then we'd love to talk. Apply today!

Expectation of working in the office 4 days a week statement: When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working give us the platform we need to connect, work at pace and challenge perceptions. That is why we work, on average, a minimum of four days per week from the office. But that does not mean we are not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

Date Posted
13-Nov-2024

Closing Date
21-Nov-2024Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.

AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.